Behaviour of breast cancer molecular subtypes through tumour progression. [artículo]
Por: Andrés Esteban, Eva [Instituto de Investigación i+12]
| Barcena García, Carmen [Anatomía Patológica] | Ciruelos Gil, Eva María [Oncología Médica] | Cortés-Funes Castro, Hernán [Oncología Médica].
Colaborador(es): Servicio de Oncología Médica | Instituto de Investigación imas12 | Servicio de Anatomía Patológica.
Editor: Clinical & Translational Oncology, 2012Descripción: 14(6):481-5.Recursos en línea: Solicitar documento Resumen: INTRODUCTION Breast cancer (BC) becomes more aggressive throughout disease progression. Clinical stage is correlated with patient outcome. We hypothesised that BC molecular subtypes are associated with a poor prognosis in advanced clinical stages. We analysed the distribution and behaviour of molecular subtypes at different BC tumour size and variation of molecular subtype in recurrent lesions.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC2583 (Navegar estantería) | Disponible |
Formato Vancouver:
Castañeda CA, Andrés E, Barcena C, Gómez HL, Cortés-Funés H, Ciruelos E. Behaviour of breast cancer molecular subtypes through tumour progression. Clin Transl Oncol. 2012 Jun;14(6):481-5.
PMID: 22634538
Contiene 25 referencias
INTRODUCTION Breast cancer (BC) becomes more aggressive throughout disease progression. Clinical stage is correlated with patient outcome. We hypothesised that BC molecular subtypes are associated with a poor prognosis in advanced clinical stages. We analysed the distribution and behaviour of molecular subtypes at different BC tumour size and variation of molecular subtype in recurrent lesions.
No hay comentarios para este ejemplar.